TheTHCReport | Green Rush News

Yield Growth Announces its Lip Balm with Hemp Oil Passes European Union Compliance Review and 250,000 Units now being Manufactured

Yield Growth Announces its Lip Balm with Hemp Oil Passes European Union Compliance Review and 250,000 Units now being Manufactured

The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce that its Urban Juve Lip Balm with Hemp Oil can now be sold in the European market. Urban Juve’s Responsible Person in Europe, Biorius, has issued a compliance certificate for the product in accordance with EU regulations.

Cannot view this image? Visit: https://media.zenfs.com/en-us/newsfile_64/fba5c4450e540ffe08f46cde3dfdc5d8

Urban Juve Lip Balm with Hemp Oil approve for sale in Europe

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6377/47025_image.jpg

Urban Juve’s Lip Balm with Hemp Oil is one of the brand’s top-selling products. The lip balm will be featured in Vogue Beauty Highlights in the October issue of UK Vogue, introducing the product to a new audience of 4.1 million readers. The lip balm will also be included in the gift bag at the ipsy Live event in New York this coming October, which will be well-attended by the beauty industry elite. Urban Juve is now manufacturing 250,000 units of its lip balm, which will be ready in September for sampling, retail sales, and e-commerce.

“We are excited about the new design of our Ultra-Hydrating Lip Balm and can’t wait to share it with hundreds of thousands of consumers through sampling and sales,” says Penny Green, CEO of Yield Growth and Urban Juve. “Through our engagement with top design agencies in New York, we are now planning a photo shoot and campaign that will showcase the Urban Juve products internationally this fall.”

Pursuant to EU regulations, Yield Growth retained Biorius to act as its Responsible Person for Urban Juve. In order to sell cosmetic products in the European Union, the Responsible Person must first issue a compliance certificate for each product. After a rigorous review of each ingredient in the lip balm, including Urban Juve’s proprietary hemp root oil, Biorius issued a certificate of compliance, confirming that Urban Juve Ultra Hydrating Lip Balm is now registered with the EU. Urban Juve now has two products registered with the EU and expects to have nine more products registered by early fall.

As proposed legislation across the European Union continues to bring cannabis closer to the mainstream, high-end cannabis products are gaining in popularity. With a total population over 508 million, the EU represents massive market potential for Urban Juve products.

About The Yield Growth Corp.

The Yield Growth Corp. develops, manufactures and distributes cannabis and hemp infused luxury product brands Urban Juve and Wright & Well and has a catalogue of over 200 wellness and beauty products in development. It intends to disrupt the international wellness market, which is a $4.2 Trillion Global Economy, according to the Global Wellness Institute, by connecting ancient healing with modern science and technology. Its management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, M·A·C Cosmetics, Skechers, Best Buy, Aritzia, Coca-Cola and Pepsi Corporation. Yield Growth serves mainstream luxury consumers who seek sophisticated wellness products. Its flagship consumer brand, Urban Juve, has proprietary, patent-pending hemp root oil extraction technology and formulas. Yield Growth is building sophisticated international distribution channels and has multiple revenue streams including licensing, services and product sales.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.com and #findyourjuve across social platforms to learn, engage and shop.

Investor Relations Contacts:

Penny Green, President & CEO
Kristina Pillon, Investor Relations
invest@yieldgrowth.com

1-833-514-BOSS 1-833-514-2677
1-833-515-BOSS 1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve and Wright & Well products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

Corporate Logo

View photos

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47025

Published at Mon, 19 Aug 2019 11:19:52 +0000

CannTrust Statement Regarding Notice of Product Return at Ontario Cannabis Store

CannTrust Statement Regarding Notice of Product Return at Ontario Cannabis Store

CannTrust Holdings Inc. (TSX: TRST, NYSE: CTST) has received a notice from the Ontario Cannabis Store, the Crown corporation in charge of wholesale distribution of cannabis products to licensed cannabis retailers in Ontario and the operator of Ontario’s online recreational cannabis store, advising the Company that the OCS has determined certain of the Company’s products sold to the OCS are Non-Conforming Products under the terms of the Master Cannabis Supply Agreement between the Company and the OCS (the “Master Agreement”) and that the OCS has elected to return these products to the Company.  Under the terms of the Master Agreement, any product that does not comply with applicable law is considered to be Non-Conforming Product and the OCS may elect to exercise its right, among others, to return such product to the Company at the Company’s expense.

CannTrust Holdings Inc. (CNW Group/CannTrust Holdings Inc.)

The products listed in the OCS return notice constitute all or substantially all of the Company’s products currently held at the OCS and are valued at approximately $2.9 million in the aggregate.  The Company intends to fully perform its obligations under the Master Agreement.  The OCS operates independently of Health Canada.  Health Canada has not ordered a recall in respect of any of the Company’s products.

About CannTrust

CannTrust is a federally regulated licensed producer of medical and recreational cannabis in Canada. Founded by pharmacists, CannTrust brings years of pharmaceutical and healthcare experience to the medical cannabis industry and serves medical patients with its dried, extract and capsule products. The Company operates its Niagara Perpetual Harvest Facility in Pelham, Ontario, and prepares and packages its product portfolio at its manufacturing centre in Vaughan, Ontario. The Company has also purchased 81 acres of land in British Columbia and expects to secure over 240 acres of land in total for low-cost outdoor cultivation which it will use for its extraction-based products.

Forward-Looking Statements

This press release contains “forward-looking information” within the meaning of Canadian Securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable United States safe harbor laws, and such statements are based upon CannTrust’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information and forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.

The forward-looking information and statements in this news release include statements relating to the return of the Company’s products, the Company’s performance under the Master Agreement, the corrective actions being taken by the Company, and Health Canada’s pending determinations. Forward-looking information and statements necessarily involve known and unknown risks, including, without limitation: actions taken in respect of the Company’s products by its customers and regulators; results of Health Canada’s investigation, including orders and compliance measures required by Health Canada and their impact on the operations, inventory, assets and financial condition of the Company; the Company’s implementation of remediation plans and related actions; regulatory approval; risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States and elsewhere; the cannabis industry in Canada generally; and, the ability of CannTrust to implement its business strategies.

Any forward-looking information and statements speak only as of the date on which they are made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. When considering these forward-looking information and statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust’s Annual Information Form dated March 28, 2019 (the “AIF”) and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and filed as an exhibit CannTrust’s Form 40-F annual report under the United States Securities Exchange Act of 1934, as amended, with the United States Securities and Exchange Commission on EDGAR at www.sec.gov. The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information or statements.

The TSX and NYSE do not accept responsibility for the adequacy or accuracy of this release.

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/canntrust-statement-regarding-notice-of-product-return-at-ontario-cannabis-store-300903336.html

SOURCE CannTrust Holdings Inc.

Published at Mon, 19 Aug 2019 11:24:46 +0000

Nevada Judge Asked to Let New Wave of Retail Cannabis Shops Open

Nevada Judge Asked to Let New Wave of Retail Cannabis Shops Open

DENVER, Aug. 19, 2019 — PRESS RELEASE — Medicine Man Technologies, Inc. has announced the entry into a binding term sheet to acquire one of Colorado’s most well-known edible and extracts companies.

Upon completion, the acquisition will expand Medicine Man Technologies’ portfolio to now include one of the state’s largest manufacturers of a nationwide, reputable lifestyle brand that has an extensive line of cannabis-infused extracts, edibles and other wellness products. Terms of the transaction consist of shares of common stock and cash valued at approximately $17.25 million, or 1.25 times anticipated annual revenue of $13.8 million. The acquisition is expected to close by the first half of 2020. The terms can also be referenced in the 8-K, which outlines the closing conditions and are conditioned upon the satisfaction or mutual waiver of certain conditions, including regulatory approval.

“This agreement will bring the manufacturer of numerous award-winning cannabis edibles and extracts under our umbrella, with existing distribution in close to 600 Colorado-based dispensaries,” said Andy Williams, co-founder and chief executive officer of Medicine Man Technologies. “These manufacturers are the creators of branded products that are market segment leaders and have won numerous awards in a multitude of categories and will further establish our leadership in Colorado. Reaching critical economies of scale, while offering depth and breadth in all cannabis product segments, is incredibly important for our business model. This acquisition, along with the others currently pending, will undoubtedly get us closer to building a vertically integrated, leading operator in Colorado. We are excited about the numerous cross-selling opportunities. This transaction will allow our products to access the massive retail reach this cannabis manufacturer already enjoys. It is our laser-focus and commitment to becoming the region’s largest producer and supplier of cannabis and cannabis products. With each acquisition, we add key industry pioneers with a similar vision and vital experience that will ultimately prove compelling to our success.”

Published at Mon, 19 Aug 2019 16:43:00 +0000

Female Founders in Their 50s Are Starting Cannabis Companies to Take Care of Their Own

Female Founders in Their 50s Are Starting Cannabis Companies to Take Care of Their Own

Jennifer Chapin, the cofounder of Kikoko, recently recalled how she was “laughed out of the dispensaries” when she tried to sell her low-dose cannabis-infused teas in her company’s early days. Three years later, Kikoko’s teas, which come in sachets and canisters wrapped with pink-and-purple stripes and cartoon flowers promising benefits such as “Sensuali-tea” and “Tranquili-tea,” are sold through over 300 storefronts and delivery services across California.

“We are a women-centric, women-owned, women-operated company,” Chapin declared to a room full of women at Arcview, a conference for cannabis investors, in Los Angeles in February. “By women, for women.”

Arcview welcomes investors irrespective of gender, but Kikoko had sponsored a women-only “tea party” (with unmedicated tea) to facilitate some female-friendly networking and announce that the company was seeking capital for expansion into new product categories, with minimum investments starting at $1 million.

Courtesy, Kikoko

Founders of female-focused cannabis startups like Kikoko may soon be laughing all the way to the bank—and they’re getting there by looking beyond millennials, and catering to women in their 40s, 50s, and beyond. Executives such as Chapin, who is 55, are listening to older women’s wishes for low-dose cannabis products that address concerns such as sleep, anxiety, and sexual pleasure, and positioning their companies at the very lucrative intersection of women, weed, and wellness.

Wellness, women, and weed

It’s a market that’s growing. Women control the majority of household purchases, and according to the US Consumer Expenditure Survey, single women over 45 spend about $640 per year on personal care items and $400 annually on drugs. As legalization takes hold, those products are increasingly likely to contain—or even be replaced by—cannabis. According to sales data and a survey of 4,000 cannabis consumers by the San Francisco-based delivery platform Eaze, the number of female cannabis consumers nearly doubled in 2018, and with their growth outpacing men, women are on track to be half of the cannabis market by 2022. Female baby boomers on the platform grew by nearly a quarter between 2017 and 2018.

Kimberly Kovacs, the cofounder and CEO of MyJane, which delivers “curated cannabis” boxes  to women (think Birchbox-meets-Eaze), was also at Arcview. That same week, her company was acquired by the cannabis logistics conglomerate MJIC for an undisclosed sum, after completing just three weeks of deliveries. MJIC CEO Sturges Karban was unabashed about the acquisition’s main attraction.

“Women are the new targets of the adult-use cannabis wellness sector,” wrote Karban, in a press release. “Yet their needs are not being addressed by the cannabis industry.”

“We don’t call that micro-dosing. We just call that normal.”

Getting stoned is not chief among those needs, Kovacs found when MyJane conducted a survey of women in Orange County, CA. When I asked what was, she didn’t skip a beat: “Sleep,” she said. “100%.”

“I don’t want to take an Ambien,” said Kovacs, who is 52, with blonde hair and clear blue eyes. “I don’t even want to take Melatonin … half a cup of tea, I sleep through the night.” (MyJane includes Kikoko tea amongst its offerings in its boxes.)

Courtesy, MyJane

In addition to better sleep, women told MyJane they were seeking relief from pain, anxiety, and stress. Many hadn’t used cannabis before and said they wanted their THC—the chemical compound that results in feeling high—in very low doses.

“By the way, we don’t call that micro-dosing,” said Kovacs. “We just call that normal.”

Ding-dong, Avon calling

Both Chapin and Kovacs referenced Avon—the 135-year-old cosmetics company known for its door-to-door saleswomen. “I don’t want to go to a dispensary,” said Kovacs. “I don’t even want to go to the grocery store anymore!”

“I don’t want to go to a dispensary. I don’t even want to go to the grocery store anymore!”

Instead, these companies strive to deliver both products and education in personal and familiar settings, outside dispensaries. Part of what they’re doing is teaching their customers how to use the range of new products available in the sector.

MyJane’s customers create online profiles answering questions about their symptoms, food allergies, preferences, and prior experience with cannabis. Then, a female “ambassador” from the company arrives at a customer’s doorstep on the agreed-upon date and time to deliver a box of selected products and walk the recipient through each one.

Kikoko’s teas are sold via dispensaries and delivery services, but the company also holds tea parties which include a “cannabis 101” slideshow about the plant’s history and benefits. Chapin estimates that in 2018, the company held over 100 of these events in private homes, country clubs, and retirement communities throughout California. (It was at a Kikiko tea party in Santa Monica that Chapin and Kovacs first met.)

Courtesy, Kikoko

Anyone for a cuppa?

Kikoko’s website has a page for people who want to host their own “High Tea Parties,” complete with downloadable images for invitations, tips (take public transit), and a Pinterest page of suggested menu items.

“We envision an army of women throughout the state of California,” said Chapin, of the consumers she hopes to recruit into hosting high teas.

Bridgett Davis, the founder of the Los Angeles-based cannabis topicals brand Big Momma’s Legacy, is also building a business based on older women customers—using a similar model of cohosting tea parties with local cannabis brands at private homes to slowly build her business from the ground up.

“It’s a group of maybe 10 to 15 of my golden girls,” she said of a typical event. “I have a variety of clients, from white ladies in Brentwood to old grandmas in Compton.”

Quartz/Jenni Avins

Bridgett Davis, the founder of Big Momma’s Legacy.

Davis agreed that a familiar setting and privacy were crucial to her customers, who use her salve and roll-on oil to ease the pain of rheumatism and sciatica, and said she’s counting on her “golden girls” to help her grow her business.

“I cannot ask for better brand ambassadors, and they’re not paid,” she said. “It’s grass-roots, and I’m building it bit by bit. When one of my seniors talks to their friend, their friend is listening.”

Riding the wellness wave

With the global wellness industry now worth an estimated $4 trillion worldwide, it’s little wonder that cannabis companies such as MyJane, Kikoko, and countless others position themselves as purveyors of supplies for self-care rather than recreation. And women—especially those in middle-age—are frequently caring not only for themselves, but also for their friends, children, and aging parents. (Kovacs told me she supplies her father with topicals for his arthritis, and her mother with tea for sleeping.) No wonder they’re tired.

Getty/manonallard

Don’t bogart that joint, girlfriend.

Both Kovacs and Chapin came to cannabis by way of a woman close to them suffering as a result of cancer. In Kovacs’ case, it was her mother-in-law, who eased her post-surgery pain and reduced her opioid use with cannabis. In Chapin’s, it was a dear friend who used edibles to aid her sleep and appetite, but was getting pummeled by high dosages. Both women saw the opportunity for products that spoke to women’s wellness.

Plus, noted MyJane cofounder Cara Raffele, “There’s a trust gap in healthcare for women.” Indeed, as Quartz’s Annaliese Griffin has written, that trust gap has made women particularly receptive to wellness brands that address their health concerns, respect their pain, and speak to them personally.

During her presentation at Arcview, Chapin said at one point, “we’re really tired of taking Ambien.” A women near me whispered under her breath: “That’s so me.”

Published at Mon, 20 May 2019 21:58:56 +0000

CV Sciences Inc (OTCMKTS:CVSI) To Move Into A Distribution Partnership With Kroger

CV Sciences Inc (OTCMKTS:CVSI) To Move Into A Distribution Partnership With Kroger

CV
Sciences Inc (OTCMKTS:CVSI)
wants to increase the competitive edge of its PlusCBD™
Oil brands. This is the reason it is moving into an expanded distribution
partnership with Kroger. The company’s product has been a best seller for quite
some time. However, there is still a need to work on distribution activities.
The new collaboration seeks to ensure customers access the original versions of
the products.

Details about the latest business deal

The  PlusCBD™ Oil
brands comprise of leading products such as the PlusCBD™ Oil Roll-Ons and the
Extra Strength Balms. CV Sciences encourages its customers to visit
its stores to obtain the PlusCBD™ Oil Roll-Ons. The
collaboration with Kroger is a major step towards boosting business for the
two.

There
are 400 Kroger stores where you can find the latest products. These stores are
spread across Virginia, Utah, Texas, Montana, and Georgia. Conducting business
with Kroger will see the business partners reap high profits from the PlusCBD™
Oil distribution.

The plans of the companies

An
official working with CV
Sciences confirms that the new collaboration is a progressive one. That is
because the business giants will have a total of 22 states to market and sell
their wide range of products. He adds that the products will be sold out in
about 1,350 Kroger stores. He said that Kroger’s
retail banners such as Pick ‘n Save, Mariano’s, QFC and Smiths were in great
condition.

According
to the official, these retail banners would help boost productivity by a
significant margin. Others are Mariano’s, King Sooper, Kroger, Fred Meyer,
Fry’s, and Dillons. In short, the decision to work with Kroger is expected to
boost business by a significant margin.

The Chief Executive Officer of CV Sciences, Joseph Dowling, opines, “We are pleased to further grow our distribution with Kroger and increase the availability of PlusCBD™ Oil products to more Kroger shoppers across the U.S.”

Top
executive says the future looks promising. If all moves according to plan, they
may be expanding their activities to sell from more of Kroger retail outlets.
However, they seek to pay close attention to safeguarding the quality of hemp
CBD products.

Published at Fri, 16 Aug 2019 12:10:14 +0000

Female Founders in Their 50s Are Starting Cannabis Companies to Take Care of Their Own

Female Founders in Their 50s Are Starting Cannabis Companies to Take Care of Their Own

Jennifer Chapin, the cofounder of Kikoko, recently recalled how she was “laughed out of the dispensaries” when she tried to sell her low-dose cannabis-infused teas in her company’s early days. Three years later, Kikoko’s teas, which come in sachets and canisters wrapped with pink-and-purple stripes and cartoon flowers promising benefits such as “Sensuali-tea” and “Tranquili-tea,” are sold through over 300 storefronts and delivery services across California.

“We are a women-centric, women-owned, women-operated company,” Chapin declared to a room full of women at Arcview, a conference for cannabis investors, in Los Angeles in February. “By women, for women.”

Arcview welcomes investors irrespective of gender, but Kikoko had sponsored a women-only “tea party” (with unmedicated tea) to facilitate some female-friendly networking and announce that the company was seeking capital for expansion into new product categories, with minimum investments starting at $1 million.

Courtesy, Kikoko

Founders of female-focused cannabis startups like Kikoko may soon be laughing all the way to the bank—and they’re getting there by looking beyond millennials, and catering to women in their 40s, 50s, and beyond. Executives such as Chapin, who is 55, are listening to older women’s wishes for low-dose cannabis products that address concerns such as sleep, anxiety, and sexual pleasure, and positioning their companies at the very lucrative intersection of women, weed, and wellness.

Wellness, women, and weed

It’s a market that’s growing. Women control the majority of household purchases, and according to the US Consumer Expenditure Survey, single women over 45 spend about $640 per year on personal care items and $400 annually on drugs. As legalization takes hold, those products are increasingly likely to contain—or even be replaced by—cannabis. According to sales data and a survey of 4,000 cannabis consumers by the San Francisco-based delivery platform Eaze, the number of female cannabis consumers nearly doubled in 2018, and with their growth outpacing men, women are on track to be half of the cannabis market by 2022. Female baby boomers on the platform grew by nearly a quarter between 2017 and 2018.

Kimberly Kovacs, the cofounder and CEO of MyJane, which delivers “curated cannabis” boxes  to women (think Birchbox-meets-Eaze), was also at Arcview. That same week, her company was acquired by the cannabis logistics conglomerate MJIC for an undisclosed sum, after completing just three weeks of deliveries. MJIC CEO Sturges Karban was unabashed about the acquisition’s main attraction.

“Women are the new targets of the adult-use cannabis wellness sector,” wrote Karban, in a press release. “Yet their needs are not being addressed by the cannabis industry.”

“We don’t call that micro-dosing. We just call that normal.”

Getting stoned is not chief among those needs, Kovacs found when MyJane conducted a survey of women in Orange County, CA. When I asked what was, she didn’t skip a beat: “Sleep,” she said. “100%.”

“I don’t want to take an Ambien,” said Kovacs, who is 52, with blonde hair and clear blue eyes. “I don’t even want to take Melatonin … half a cup of tea, I sleep through the night.” (MyJane includes Kikoko tea amongst its offerings in its boxes.)

Courtesy, MyJane

In addition to better sleep, women told MyJane they were seeking relief from pain, anxiety, and stress. Many hadn’t used cannabis before and said they wanted their THC—the chemical compound that results in feeling high—in very low doses.

“By the way, we don’t call that micro-dosing,” said Kovacs. “We just call that normal.”

Ding-dong, Avon calling

Both Chapin and Kovacs referenced Avon—the 135-year-old cosmetics company known for its door-to-door saleswomen. “I don’t want to go to a dispensary,” said Kovacs. “I don’t even want to go to the grocery store anymore!”

“I don’t want to go to a dispensary. I don’t even want to go to the grocery store anymore!”

Instead, these companies strive to deliver both products and education in personal and familiar settings, outside dispensaries. Part of what they’re doing is teaching their customers how to use the range of new products available in the sector.

MyJane’s customers create online profiles answering questions about their symptoms, food allergies, preferences, and prior experience with cannabis. Then, a female “ambassador” from the company arrives at a customer’s doorstep on the agreed-upon date and time to deliver a box of selected products and walk the recipient through each one.

Kikoko’s teas are sold via dispensaries and delivery services, but the company also holds tea parties which include a “cannabis 101” slideshow about the plant’s history and benefits. Chapin estimates that in 2018, the company held over 100 of these events in private homes, country clubs, and retirement communities throughout California. (It was at a Kikiko tea party in Santa Monica that Chapin and Kovacs first met.)

Courtesy, Kikoko

Anyone for a cuppa?

Kikoko’s website has a page for people who want to host their own “High Tea Parties,” complete with downloadable images for invitations, tips (take public transit), and a Pinterest page of suggested menu items.

“We envision an army of women throughout the state of California,” said Chapin, of the consumers she hopes to recruit into hosting high teas.

Bridgett Davis, the founder of the Los Angeles-based cannabis topicals brand Big Momma’s Legacy, is also building a business based on older women customers—using a similar model of cohosting tea parties with local cannabis brands at private homes to slowly build her business from the ground up.

“It’s a group of maybe 10 to 15 of my golden girls,” she said of a typical event. “I have a variety of clients, from white ladies in Brentwood to old grandmas in Compton.”

Quartz/Jenni Avins

Bridgett Davis, the founder of Big Momma’s Legacy.

Davis agreed that a familiar setting and privacy were crucial to her customers, who use her salve and roll-on oil to ease the pain of rheumatism and sciatica, and said she’s counting on her “golden girls” to help her grow her business.

“I cannot ask for better brand ambassadors, and they’re not paid,” she said. “It’s grass-roots, and I’m building it bit by bit. When one of my seniors talks to their friend, their friend is listening.”

Riding the wellness wave

With the global wellness industry now worth an estimated $4 trillion worldwide, it’s little wonder that cannabis companies such as MyJane, Kikoko, and countless others position themselves as purveyors of supplies for self-care rather than recreation. And women—especially those in middle-age—are frequently caring not only for themselves, but also for their friends, children, and aging parents. (Kovacs told me she supplies her father with topicals for his arthritis, and her mother with tea for sleeping.) No wonder they’re tired.

Getty/manonallard

Don’t bogart that joint, girlfriend.

Both Kovacs and Chapin came to cannabis by way of a woman close to them suffering as a result of cancer. In Kovacs’ case, it was her mother-in-law, who eased her post-surgery pain and reduced her opioid use with cannabis. In Chapin’s, it was a dear friend who used edibles to aid her sleep and appetite, but was getting pummeled by high dosages. Both women saw the opportunity for products that spoke to women’s wellness.

Plus, noted MyJane cofounder Cara Raffele, “There’s a trust gap in healthcare for women.” Indeed, as Quartz’s Annaliese Griffin has written, that trust gap has made women particularly receptive to wellness brands that address their health concerns, respect their pain, and speak to them personally.

During her presentation at Arcview, Chapin said at one point, “we’re really tired of taking Ambien.” A women near me whispered under her breath: “That’s so me.”

Published at Mon, 20 May 2019 21:58:56 +0000

Female Founders in Their 50s Are Starting Cannabis Companies to Take Care of Their Own

Female Founders in Their 50s Are Starting Cannabis Companies to Take Care of Their Own

Jennifer Chapin, the cofounder of Kikoko, recently recalled how she was “laughed out of the dispensaries” when she tried to sell her low-dose cannabis-infused teas in her company’s early days. Three years later, Kikoko’s teas, which come in sachets and canisters wrapped with pink-and-purple stripes and cartoon flowers promising benefits such as “Sensuali-tea” and “Tranquili-tea,” are sold through over 300 storefronts and delivery services across California.

“We are a women-centric, women-owned, women-operated company,” Chapin declared to a room full of women at Arcview, a conference for cannabis investors, in Los Angeles in February. “By women, for women.”

Arcview welcomes investors irrespective of gender, but Kikoko had sponsored a women-only “tea party” (with unmedicated tea) to facilitate some female-friendly networking and announce that the company was seeking capital for expansion into new product categories, with minimum investments starting at $1 million.

Courtesy, Kikoko

Founders of female-focused cannabis startups like Kikoko may soon be laughing all the way to the bank—and they’re getting there by looking beyond millennials, and catering to women in their 40s, 50s, and beyond. Executives such as Chapin, who is 55, are listening to older women’s wishes for low-dose cannabis products that address concerns such as sleep, anxiety, and sexual pleasure, and positioning their companies at the very lucrative intersection of women, weed, and wellness.

Wellness, women, and weed

It’s a market that’s growing. Women control the majority of household purchases, and according to the US Consumer Expenditure Survey, single women over 45 spend about $640 per year on personal care items and $400 annually on drugs. As legalization takes hold, those products are increasingly likely to contain—or even be replaced by—cannabis. According to sales data and a survey of 4,000 cannabis consumers by the San Francisco-based delivery platform Eaze, the number of female cannabis consumers nearly doubled in 2018, and with their growth outpacing men, women are on track to be half of the cannabis market by 2022. Female baby boomers on the platform grew by nearly a quarter between 2017 and 2018.

Kimberly Kovacs, the cofounder and CEO of MyJane, which delivers “curated cannabis” boxes  to women (think Birchbox-meets-Eaze), was also at Arcview. That same week, her company was acquired by the cannabis logistics conglomerate MJIC for an undisclosed sum, after completing just three weeks of deliveries. MJIC CEO Sturges Karban was unabashed about the acquisition’s main attraction.

“Women are the new targets of the adult-use cannabis wellness sector,” wrote Karban, in a press release. “Yet their needs are not being addressed by the cannabis industry.”

“We don’t call that micro-dosing. We just call that normal.”

Getting stoned is not chief among those needs, Kovacs found when MyJane conducted a survey of women in Orange County, CA. When I asked what was, she didn’t skip a beat: “Sleep,” she said. “100%.”

“I don’t want to take an Ambien,” said Kovacs, who is 52, with blonde hair and clear blue eyes. “I don’t even want to take Melatonin … half a cup of tea, I sleep through the night.” (MyJane includes Kikoko tea amongst its offerings in its boxes.)

Courtesy, MyJane

In addition to better sleep, women told MyJane they were seeking relief from pain, anxiety, and stress. Many hadn’t used cannabis before and said they wanted their THC—the chemical compound that results in feeling high—in very low doses.

“By the way, we don’t call that micro-dosing,” said Kovacs. “We just call that normal.”

Ding-dong, Avon calling

Both Chapin and Kovacs referenced Avon—the 135-year-old cosmetics company known for its door-to-door saleswomen. “I don’t want to go to a dispensary,” said Kovacs. “I don’t even want to go to the grocery store anymore!”

“I don’t want to go to a dispensary. I don’t even want to go to the grocery store anymore!”

Instead, these companies strive to deliver both products and education in personal and familiar settings, outside dispensaries. Part of what they’re doing is teaching their customers how to use the range of new products available in the sector.

MyJane’s customers create online profiles answering questions about their symptoms, food allergies, preferences, and prior experience with cannabis. Then, a female “ambassador” from the company arrives at a customer’s doorstep on the agreed-upon date and time to deliver a box of selected products and walk the recipient through each one.

Kikoko’s teas are sold via dispensaries and delivery services, but the company also holds tea parties which include a “cannabis 101” slideshow about the plant’s history and benefits. Chapin estimates that in 2018, the company held over 100 of these events in private homes, country clubs, and retirement communities throughout California. (It was at a Kikiko tea party in Santa Monica that Chapin and Kovacs first met.)

Courtesy, Kikoko

Anyone for a cuppa?

Kikoko’s website has a page for people who want to host their own “High Tea Parties,” complete with downloadable images for invitations, tips (take public transit), and a Pinterest page of suggested menu items.

“We envision an army of women throughout the state of California,” said Chapin, of the consumers she hopes to recruit into hosting high teas.

Bridgett Davis, the founder of the Los Angeles-based cannabis topicals brand Big Momma’s Legacy, is also building a business based on older women customers—using a similar model of cohosting tea parties with local cannabis brands at private homes to slowly build her business from the ground up.

“It’s a group of maybe 10 to 15 of my golden girls,” she said of a typical event. “I have a variety of clients, from white ladies in Brentwood to old grandmas in Compton.”

Quartz/Jenni Avins

Bridgett Davis, the founder of Big Momma’s Legacy.

Davis agreed that a familiar setting and privacy were crucial to her customers, who use her salve and roll-on oil to ease the pain of rheumatism and sciatica, and said she’s counting on her “golden girls” to help her grow her business.

“I cannot ask for better brand ambassadors, and they’re not paid,” she said. “It’s grass-roots, and I’m building it bit by bit. When one of my seniors talks to their friend, their friend is listening.”

Riding the wellness wave

With the global wellness industry now worth an estimated $4 trillion worldwide, it’s little wonder that cannabis companies such as MyJane, Kikoko, and countless others position themselves as purveyors of supplies for self-care rather than recreation. And women—especially those in middle-age—are frequently caring not only for themselves, but also for their friends, children, and aging parents. (Kovacs told me she supplies her father with topicals for his arthritis, and her mother with tea for sleeping.) No wonder they’re tired.

Getty/manonallard

Don’t bogart that joint, girlfriend.

Both Kovacs and Chapin came to cannabis by way of a woman close to them suffering as a result of cancer. In Kovacs’ case, it was her mother-in-law, who eased her post-surgery pain and reduced her opioid use with cannabis. In Chapin’s, it was a dear friend who used edibles to aid her sleep and appetite, but was getting pummeled by high dosages. Both women saw the opportunity for products that spoke to women’s wellness.

Plus, noted MyJane cofounder Cara Raffele, “There’s a trust gap in healthcare for women.” Indeed, as Quartz’s Annaliese Griffin has written, that trust gap has made women particularly receptive to wellness brands that address their health concerns, respect their pain, and speak to them personally.

During her presentation at Arcview, Chapin said at one point, “we’re really tired of taking Ambien.” A women near me whispered under her breath: “That’s so me.”

Published at Mon, 20 May 2019 21:58:56 +0000

CannTrust Provides Additional Insight Into Their Growing Dumpster Fire Of A Canadian Licensed Producer

CannTrust Provides Additional Insight Into Their Growing Dumpster Fire Of A Canadian Licensed Producer

CannTrust Holdings Inc. (TSX: TRST, NYSE: CTST) today provided an interim update on various matters.

CannTrust Holdings Inc. (CNW Group/CannTrust Holdings Inc.)

Management Cease Trade Order

CannTrust announced that its application for a management cease trade order (“MCTO”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”) has been approved by the Ontario Securities Commission (“OSC”). The MCTO does not affect the ability of investors who are not insiders to trade in the securities of the Company.

CannTrust announced on August 1, 2019 that it was filing an application seeking a MCTO from the OSC because the Company was likely to miss its filing deadline of August 14, 2019 to file an interim financial report for the three and six month periods ended June 30, 2019, an interim management’s discussion and analysis for the corresponding period and certifications of interim filings (the “Q2 Financials”).

The timing and content of CannTrust restoring any defaults in its Q2 Financials will depend, in large measure, upon the timing and impact of Health Canada’s decisions regarding the Company’s non-compliance with regulatory requirements. Although the Company, under the supervision of the Special Committee, is preparing a remediation plan for submission to, and consideration by Health Canada, Health Canada has advised the Company that it is unable to provide any guidance about the timing or content of its decisions concerning the Company.

The MCTO prohibits the directors and executive officers of the Company from trading in securities of the Company until two full business days after all filings CannTrust is required to make under Ontario securities laws are made, including filing of the Q2 Financials. The MCTO does not affect the ability of any other persons to trade in the securities of the Company. CannTrust had already voluntarily imposed a blackout period on its directors and executive officers trading in the Company’s securities.

The Company intends to satisfy the provisions of the alternative information guidelines in NP 12-203 by filing bi-weekly status reports in the form of news releases containing prescribed updating information until the Q2 Financials are filed.

New York Stock Exchange Discussions

The Company has been working pro-actively with the New York Stock Exchange (“NYSE”) to keep the NYSE apprised of its interactions with Health Canada and related matters. Following a discussion on August 9, 2019 between representatives of the NYSE, the Company, the Company’s counsel and counsel to the Company’s special committee of independent directors (the “Special Committee”), the NYSE advised the Company that as a consequence of the Company’s announcements concerning its audited financial statements for the year ended December 31, 2018 and its unaudited financial statements for the quarter ended March 31, 2019, the Company is viewed as no longer having a complete annual report on Form 40-F on file for the year ended December 31, 2018.

Trading of the Company’s securities on the TSX and NYSE continues.  However, the NYSE advised the Company that (a) it will closely monitor the status of the Company’s late filing and any related public disclosures for up to six months from its due date, and (b) if the Company fails to file its annual report and any subsequent reports within six months of their filing due dates, the NYSE will determine, in its sole discretion, whether to halt trading in the Company’s securities or whether to allow the Company’s securities to trade for up to an additional six months, depending upon the circumstances. If the NYSE determines that an additional six-month trading period is not appropriate, suspension and delisting procedures will commence pursuant to Section 804.00 of the NYSE’s Listed Company Manual. Regardless of the procedures described above, the NYSE may commence delisting proceedings at any time during the period that is available to complete the filing, if circumstances warrant.

Interim Financial Update

As previously disclosed, the Company estimates the value of the inventory and biological assets impacted by the pending Health Canada decisions is approximately $51 million as at June 30, 2019. Management of the Company further estimates the impacted inventory represents approximately 53% of the Company’s total inventory as at June 30, 2019 and the impacted biological assets represent approximately 30% of the Company’s total biological assets as at June 30, 2019.

As at June 30, 2019, the Company had approximately $250 million in cash and cash equivalents.

Remediation Efforts

Under the supervision of the Special Committee, the Company is preparing a remediation plan for submission to and consideration by Health Canada.  Although the Special Committee is directing the Company to work closely with Health Canada to remediate the root causes of any non-compliance identified by Health Canada, to date the Company has not had any substantive discussions with Health Canada concerning remediation matters and Health Canada has advised the Company that it is currently unable to provide any guidance about the timing or content of its decisions concerning the Company.  As previously announced, Health Canada has placed a hold on inventory which includes approximately 5,200kg of dried cannabis that was harvested in the previously unlicensed rooms in Pelham, until it deems that the Company is compliant with regulations. In addition, CannTrust has instituted a voluntary hold of approximately 7,500kg of dried cannabis equivalent at its Vaughan manufacturing facility that was produced in the previously unlicensed rooms.  Health Canada has broad discretion to exercise a wide range of regulatory powers.  In the event that Health Canada orders the destruction of all or a substantial portion of the product grown in the previously unlicensed rooms, the Company’s results for the second quarter of 2019 would be materially adversely impacted.  Health Canada has given no clear indication of what decisions it will come to with respect to the Company.

About CannTrust

CannTrust is a federally regulated licensed producer of medical and recreational cannabis in Canada. Founded by pharmacists, CannTrust brings years of pharmaceutical and healthcare experience to the medical cannabis industry and serves medical patients with its dried, extract and capsule products. The Company operates its Niagara Perpetual Harvest Facility in Pelham, Ontario, and prepares and packages its product portfolio at its manufacturing centre in Vaughan, Ontario. The Company has also purchased 81 acres of land in British Columbia and expects to secure over 240 acres of land in total for low-cost outdoor cultivation which it will use for its extraction-based products.

Forward-Looking Statements

This press release contains “forward-looking information” within the meaning of Canadian Securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable United States safe harbor laws, and such statements are based upon CannTrust’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information and forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.

The forward-looking information and statements in this news release include statements relating to the corrective actions being taken by the Company, Health Canada’s pending determinations (including with respect to the Company’s inventory and biological assets) and the NYSE’s ongoing monitoring of the Company’s late filings and its decision on whether to halt trading in the Company’s securities. Forward-looking information and statements necessarily involve known and unknown risks, including, without limitation: results of Health Canada’s investigation, including orders and compliance measures required by Health Canada and their impact on the operations, inventory, assets and financial condition of the Company; the Company’s implementation of remediation plans and related actions; the timing and content of restoring any defaults in its continuous disclosure filings; the Company’s ability to file its annual report and any subsequent delayed filings; whether the NYSE commences delisting proceedings at any time; regulatory approval; risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States and elsewhere; the cannabis industry in Canada generally; and, the ability of CannTrust to implement its business strategies.

Any forward-looking information and statements speak only as of the date on which they are made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. When considering these forward-looking information and statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust’s Annual Information Form dated March 28, 2019 (the “AIF”) and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and filed as an exhibit CannTrust’s Form 40-F annual report under the United States Securities Exchange Act of 1934, as amended, with the United States Securities and Exchange Commission on EDGAR at www.sec.gov. The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information or statements.

The TSX and NYSE do not accept responsibility for the adequacy or accuracy of this release.

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/canntrust-announces-receipt-of-management-cease-trade-order-and-provides-interim-update-300902798.html

SOURCE CannTrust Holdings Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2019/15/c6302.html

Published at Fri, 16 Aug 2019 11:09:52 +0000

3 U.S. Cannabis Stocks Trading Under Pressure Despite Consistent Execution

3 U.S. Cannabis Stocks Trading Under Pressure Despite Consistent Execution

Earlier this week, we published the first part of a two-article series that covers the recent performance of the cannabis industry.

The initial article focused on companies that are in the Canadian cannabis sector. Today’s article will cover 3 companies that are focused on the US cannabis market. The US companies represent emerging growth opportunities that have been laser focused on execution and are businesses that we are closely watching.

1933 Industries: A Burgeoning THC and CBD Execution Story

Las Vegas has transformed into one of the most attractive US markets for cannabis businesses. This is an opportunity that we have been closely watching following the opening of the recreational market in July 2016. A few months ago, we traveled to Sin City to visit 1933 Industries (TGIF.CN) (TGIFF), a company that has been laser focused on the Las Vegas cannabis market.

Last month, 1933 Industries reported to have received final approvals from both Clark County and Nevada’s Department of Taxation for the transfer of its existing cultivation licenses to the new cultivation facility. The new facility is almost 5 times larger than the initial facility and is expected to be able to produce approx. 700 to 800 pounds of dried cannabis per month.

Although we are bullish on the growth prospects associated with the new facility, 1933 Industries has been under pressure. During the back half of the year, we expect production capacity to ramp higher and for 1933 Industries to recognize the benefits associated with the facility. We have highlighted several of the recent developments that we have found to be significant:

  • August 15th – 1933 Industries officially entered the California cannabis market via an agreement with Green Spectrum Trading, Inc.. Under the terms of the Agreement, the Company will provide the services necessary for the operation of Green Spectrum’s business, including oversight over the general management of the business and operations, product manufacturing, distribution efforts, staffing, sales, marketing, accounting, and compliance.
  • July 19th – 1933 Industries reported to have received final approvals from both Clark County and Nevada Department of Taxation for the transfer of its existing cultivation licenses to its new cultivation facility, which completes all the necessary steps to begin the transfer of its cannabis plants.
  • July 12th – 1933 Industries expanded its concentrate production area from 483 sq. ft. to 2,215 sq. ft. in the current facility. The expected distillate production capacity will increase from 40 liters per month to 80 liters per month in order to secure the supply for its branded products as well as for its white label partners.
  • July 2nd – 1933 Industries reported to have generated $4.6 million of revenue in the third quarter of 2019.
  • June 17th – 1933 Industries reported to be distributing Canna Hemp products to more than 800 retail outlets, with coast-to-coast distribution in the US.
  • June 6th –1933 Industries appointed Ester Vigil as President of the company and Caleb Zobrist as Executive Vice President
  • May 31st – 1933 Industries appointed Chris Rebentisch as Chief Executive Officer, overseeing the company’s operations going forward. Brayden Sutton will remain Chairman of the Board of Directors.
  • May 15th – 1933 Industries completed a sale and lease back for its newly constructed cannabis cultivation facility in Las Vegas. The purchase price for the transaction was $10,450,000 which included the cultivation facility as well as the 1.39 acres of land it sits on.
  • April 29th – 1933 Industries reported to be progressing with its plans to launch one of Nevada’s largest hemp extraction facilities and to add a new significant revenue stream to its business model.
  • April 9th – 1933 Industries announced a licensing agreement with OG DNA Genetics, a globally recognized leading cannabis brand, for the exclusive license to cultivate, manufacture, sell and distribute co-branded cannabis products for a two-year term in Nevada.
  • April 8th – 1933 Industries executed a licensing agreement with House of Hawk for the launch of several co-branded CBD wellness products for a two-year term in North America.
  • March 28th – 1933 Industries signed a membership interest purchase definitive agreement to acquire the remaining 9% of Infused MFG.
  • March 15th – 1933 Industries closed its previously announced non-brokered private placement which raised total proceeds of $4.5 million.

Liberty Health Sciences: A Florida Cannabis Firm to be Watching

Another US focused cannabis company that is worth highlighting is Liberty Health Sciences (LHS.CN) (LHSIF), which has been highly focused on the medical cannabis sector in Florida. So far this year, the company has been executing flawlessly and has opened several new dispensaries in the state of Florida.

In late July, Liberty Health Sciences reported first quarter financial results and these numbers showed strong growth when compared to the prior quarter. Going forward, this is a trend that we expect to continue and this is due to the steady increase in the number of operational medical cannabis dispensaries.

Although Liberty Health Sciences has done a great job at increasing market share in Florida, the shares have been trading lower with the market. We have highlighted some of the most significant developments that have been reported since mid-March:

  • July 31st – Liberty Health Sciences reported $5.5+ million of revenue for the quarter that ended on May 31st, much higher than the $1,141,118 reported during the same period last year. Gross profit for the quarter was $5,018,399 and this was much higher than the $606,178 reported during the same period last year.
  • July 24th – Liberty Health Sciences announced that it had the second highest sales of smokable cannabis in Florida with 16 dispensaries open.
  • June 17th – Liberty Health Sciences announced that it will open its 16th dispensary in Tallahassee, Florida
  • June 11th – Liberty Health Sciences announced that it will open its 15th dispensary in Boca Raton
  • June 10th – Liberty Health Sciences announced that it is continuing to expand its product offerings by introducing two additional brands: Papa’s Herb and Lemon and Grass, subject to Florida Department of Health approval.
  • June 6th – Liberty Health Sciences announced that it will be introducing Zentient to all of its dispensaries as its new house brand of products along with Pretty Pistil, subject to the Florida Department of Health approval. Pretty Pistil will be replacing all of Liberty’s Solei branded products.
  • May 22nd – Liberty Health Sciences appointed Sheri Cholodofsky as Chief Financial Officer who replaces Jeff Chan who had served as interim CFO following the resignation of Rene Gulliver as CFO. Chan will resume his duties at Liberty as Vice President, Finance and will work closely with Cholodofsky during this transition period.
  • May 6th – Liberty Health Sciences announced that it will open its 14th Florida dispensary in Cape Coral’s South Cape business district
  • April 23rd – Liberty Health Sciences successfully launched sales of its whole flower smokable products as well as its pre-rolled cannabis cigarette products this past weekend.
  • April 3rd – Liberty Health Sciences announced that it will open its 13th Florida dispensary in Bonita Springs. The company also received approval for an additional use of 80,000 sq. ft. of enclosed greenhouse space at the Liberty 360 Innovation campus in Gainesville. This brings the company to a total of 228,880 sq. ft. of cultivation space in the Gainesville area.
  • April 1st – Liberty Health Sciences received Florida Department of Health (DOH) approval on March 26th to sell pre-rolls along with whole flower smokable products to patients.
  • March 25th – Liberty Health Sciences received Florida Department of Health (DOH) approval to sell whole flower smokable products to patients in Florida, making it one of the first companies in the state to provide smokable medical marijuana in all of its dispensaries.
  • March 15th – Liberty Health Sciences announced that it is continuing its expansion in Florida and is on schedule to open its 12th dispensary in Gainesville

Green Thumb Industries: A US Leader in the Making

Green Thumb Industries (GTII.CN) (GTBIF) is a US cannabis retailer that we have been excited about and have been closely following. Green Thumb CEO Ben Kovler is the heir to the Jim Beam empire and we are favorable on how he has been able to drive the story forward.

Although the US cannabis retailer has been nothing short of an execution story and is well capitalized to continue to expand its reach across the country, the shares have been under pressure with the rest of the cannabis sector. Today, we have issued an update on the US cannabis retailer and this is an opportunity that we continue to watch.

  • July 30th – Green Thumb announced that it will open its 27th location, Rise Cleveland. This is the third Rise store in Ohio and the city’s first cannabis retail store.
  • July 25th – Green Thumb announced that it is one of only three companies to be awarded a new retail license by Culver City, located in Los Angeles County, California.
  • July 9th – Green Thumb announced that it will open its fourth retail location in Florida, its 26th open location in the country.
  • June 25th –Green Thumb announced that it will open Rise Mechanicsburg, its sixth retail location in Pennsylvania and 25th in the nation
  • June 18th – Green Thumb announced that it will open its fifth retail location in Pennsylvania, which is located in the Pittsburgh metropolitan area
  • June 6th – Green Thumb was awarded a retail dispensary and delivery license by the City of Pasadena, making it one of only six new licenses in Pasadena.
  • June 5th – Green Thumb Industries closed on the acquisition of Integral Associates. The acquisition includes: three high-traffic retail stores located across the Las Vegas area; and eight additional retail licenses in Nevada (five in the Las Vegas area and three in Northern Nevada); West Hollywood retail license, one of only five with a consumption lounge and delivery service; Desert Grown Farms, a 54,000 square foot state-of-the-art cultivation and processing facility with an award-winning genetics library of 100+ strains; and Cannabiotix NV, a 41,000 square foot cultivation and processing facility
  • May 31st – Green Thumb announced that it will open its third retail location in Florida and 20th in the country
  • May 30th – Green Thumb reported that it generated $28 million in revenue during the first quarter that ended on March 31st
  • May 8th – Green Thumb announced that Rise Amherst will begin selling cannabis to adults aged 21 and over in Massachusetts.
  • April 26th – Green Thumb announced that it will open its second retail location in Florida

Pursuant to an agreement between StoneBridge Partners LLC and 1933 Industries we have been hired for a period of 180 days beginning July 15, 2019 and ending January 15, 2020 to publicly disseminate information about (TGIF) including on the Website and other media including Facebook and Twitter. We are being paid $7,500 per month for a period of 6 months. We own zero shares of (TGIF), which we purchased in the open market. We plan to sell the “ZERO” shares of (TGIF) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (TGIF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Share

Share - Facebook


Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Fri, 16 Aug 2019 11:48:34 +0000

1933 Industries Grants Stock Options and Cancels Extraordinary Meeting of Debentureholders

1933 Industries Grants Stock Options and Cancels Extraordinary Meeting of Debentureholders

1933 Industries Inc. (TGIF.CN) (TGIFF), a vertically integrated cannabis consumer packaged goods company, announces the grant of 6,800,000 incentive stock options to its directors, officers, consultants and employees pursuant to the Company’s stock option plan.  The options are exercisable for a period of three years at a price of $0.35 per share and will vest over a three-year period.

Further to the Company’s announcement that it would hold a meeting of debenture holders holding 10% unsecured convertible debentures with an expiry date of September 14, 2021 (“Debentures”), the Company has determined not to pursue the amendment to the Debentures and is therefore cancelling the meeting scheduled for August 28, 2019.  The payment of interest will be made in cash.

The Company reminds holders of warrants expiring on August 16, 2019 of the deadline today.

About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated, brand-focused cannabis company with operations in the United States and Canada. Operating through two subsidiary companies, the Company owns leading cannabis brands as well as licensed cannabis cultivation, extraction, processing and manufacturing assets. With the goal of delivering natural wellness, our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates, CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™. Partners under licensing agreements include Denver Dab Co., Birdhouse Skateboards™, Gotti’s Gold and Kurupt Moonrocks. The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG.

About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018.
http://www.cannahemp.com
https://www.leafly.com/news/strains-products/best-in-state-2018-nevada-cannabis

About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance.
http://www.cannahempx.com
https://herb.co/learn/best-cannabis-products/

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct.  Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Share

Share - Facebook


Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Fri, 16 Aug 2019 12:52:56 +0000






THC REPORT





Your subscription could not be saved. Please try again.




Your subscription has been successful.

Subscribe now

Subscribe to our newsletter and stay updated.